[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Antivenom Market 2017 Forecast to 2022

March 2018 | 118 pages | ID: GA719FB4686EN
GlobalInfoResearch

US$ 4,880.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.

Scope of the Report:

This report focuses on the Antivenom in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
  • CSL Behring
  • Merck & Co., Inc.
  • BTG Plc
  • Pfizer
  • Haffkine Bio-Pharmaceutical Corporation
  • Rare Disease Therapeutics
  • Flynn Pharma
  • Vins Bioproducts
  • Bharat Serums and Vaccines
  • Serum Biotech
Market Segment by Regions, regional analysis covers
  • North America (USA, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Columbia etc.)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
  • Polyvalent antivenom
  • Monovalent antivenom
Market Segment by Applications, can be divided into
  • Retail Pharmacies
  • Hospitals
  • Others
There are 15 Chapters to deeply display the global Antivenom market.

Chapter 1, to describe Antivenom Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Antivenom, with sales, revenue, and price of Antivenom, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Antivenom, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Antivenom market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Antivenom sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
1 MARKET OVERVIEW

1.1 Antivenom Introduction
1.2 Market Analysis by Type
  1.2.1 Polyvalent antivenom
  1.2.2 Monovalent antivenom
1.3 Market Analysis by Applications
  1.3.1 Retail Pharmacies
  1.3.2 Hospitals
  1.3.3 Others
1.4 Market Analysis by Regions
  1.4.1 North America (USA, Canada and Mexico)
    1.4.1.1 USA Market States and Outlook (2012-2022)
    1.4.1.2 Canada Market States and Outlook (2012-2022)
    1.4.1.3 Mexico Market States and Outlook (2012-2022)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2012-2022)
    1.4.2.2 France Market States and Outlook (2012-2022)
    1.4.2.3 UK Market States and Outlook (2012-2022)
    1.4.2.4 Russia Market States and Outlook (2012-2022)
    1.4.2.5 Italy Market States and Outlook (2012-2022)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2012-2022)
    1.4.3.2 Japan Market States and Outlook (2012-2022)
    1.4.3.3 Korea Market States and Outlook (2012-2022)
    1.4.3.4 India Market States and Outlook (2012-2022)
    1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2012-2022)
    1.4.4.2 Egypt Market States and Outlook (2012-2022)
    1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
    1.4.4.4 South Africa Market States and Outlook (2012-2022)
    1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 CSL Behring
  2.1.1 Business Overview
    2.1.1.1 CSL Behring Antivenom Description
    2.1.1.2 CSL Behring Antivenom Headquarter, Main Business and Finance Overview
  2.1.2 CSL Behring Antivenom Product Introduction
    2.1.2.1 Production Bases, Sales Regions and Major Competitors
    2.1.2.2 CSL Behring Antivenom Product Introduction
  2.1.3 CSL Behring Antivenom Sales, Revenue and Market Share
    2.1.3.1 CSL Behring Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 CSL Behring Antivenom Market Share in Global in 2016
2.2 Merck & Co., Inc.
  2.2.1 Business Overview
    2.2.1.1 Merck & Co., Inc. Antivenom Description
    2.2.1.2 Merck & Co., Inc. Antivenom Headquarter, Main Business and Finance Overview
  2.2.2 CSL Behring Antivenom Product Introduction
    2.2.2.1 Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Merck & Co., Inc. Antivenom Product Introduction
  2.2.3 Merck & Co., Inc. Antivenom Sales, Revenue and Market Share
    2.2.3.1 Merck & Co., Inc. Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Merck & Co., Inc. Antivenom Market Share in Global in 2016
2.3 BTG Plc
  2.3.1 Business Overview
    2.3.1.1 BTG Plc Antivenom Description
    2.3.1.2 BTG Plc Antivenom Headquarter, Main Business and Finance Overview
  2.3.2 BTG Plc Antivenom Product Introduction
    2.3.2.1 Production Bases, Sales Regions and Major Competitors
    2.3.2.2 BTG Plc Antivenom Product Introduction
  2.3.3 BTG Plc Antivenom Sales, Revenue and Market Share
    2.3.3.1 BTG Plc Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 BTG Plc Antivenom Market Share in Global in 2016
2.4 Pfizer
  2.4.1 Business Overview
    2.4.1.1 Pfizer Antivenom Description
    2.4.1.2 Pfizer Antivenom Headquarter, Main Business and Finance Overview
  2.4.2 Pfizer Antivenom Product Introduction
    2.4.2.1 Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Pfizer Antivenom Product Introduction
  2.4.3 Pfizer Antivenom Sales, Revenue and Market Share
    2.4.3.1 Pfizer Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Pfizer Antivenom Market Share in Global in 2016
2.5 Haffkine Bio-Pharmaceutical Corporation
  2.5.1 Business Overview
    2.5.1.1 Haffkine Bio-Pharmaceutical Corporation Antivenom Description
    2.5.1.2 Haffkine Bio-Pharmaceutical Corporation Antivenom Headquarter, Main Business and Finance Overview
  2.5.2 Haffkine Bio-Pharmaceutical Corporation Antivenom Product Introduction
    2.5.2.1 Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Haffkine Bio-Pharmaceutical Corporation Antivenom Product Introduction
  2.5.3 Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Revenue and Market Share
    2.5.3.1 Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Haffkine Bio-Pharmaceutical Corporation Antivenom Market Share in Global in 2016
2.6 Rare Disease Therapeutics
  2.6.1 Business Overview
    2.6.1.1 Rare Disease Therapeutics Antivenom Description
    2.6.1.2 Rare Disease Therapeutics Antivenom Headquarter, Main Business and Finance Overview
  2.6.2 Rare Disease Therapeutics Antivenom Product Introduction
    2.6.2.1 Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Rare Disease Therapeutics Antivenom Product Introduction
  2.6.3 Rare Disease Therapeutics Antivenom Sales, Revenue and Market Share
    2.6.3.1 Rare Disease Therapeutics Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Rare Disease Therapeutics Antivenom Market Share in Global in 2016
2.7 Flynn Pharma
  2.7.1 Business Overview
    2.7.1.1 Flynn Pharma Antivenom Description
    2.7.1.2 Flynn Pharma Antivenom Headquarter, Main Business and Finance Overview
  2.7.2 Flynn Pharma Antivenom Product Introduction
    2.7.2.1 Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Flynn Pharma Antivenom Product Introduction
  2.7.3 Flynn Pharma Antivenom Sales, Revenue and Market Share
    2.7.3.1 Flynn Pharma Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Flynn Pharma Antivenom Market Share in Global in 2016
2.8 Vins Bioproducts
  2.8.1 Business Overview
    2.8.1.1 Vins Bioproducts Antivenom Description
    2.8.1.2 Vins Bioproducts Antivenom Headquarter, Main Business and Finance Overview
  2.8.2 Vins Bioproducts Antivenom Product Introduction
    2.8.2.1 Production Bases, Sales Regions and Major Competitors
    2.8.2.2 Vins Bioproducts Antivenom Product Introduction
  2.8.3 Vins Bioproducts Antivenom Sales, Revenue and Market Share
    2.8.3.1 Vins Bioproducts Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.2 Vins Bioproducts Antivenom Market Share in Global in 2016
2.9 Bharat Serums and Vaccines
  2.9.1 Business Overview
    2.9.1.1 Bharat Serums and Vaccines Antivenom Description
    2.9.1.2 Bharat Serums and Vaccines Antivenom Headquarter, Main Business and Finance Overview
  2.9.2 Bharat Serums and Vaccines Antivenom Product Introduction
    2.9.2.1 Production Bases, Sales Regions and Major Competitors
    2.9.2.2 Bharat Serums and Vaccines Antivenom Product Introduction
  2.9.3 Bharat Serums and Vaccines Antivenom Sales, Revenue and Market Share
    2.9.3.1 Bharat Serums and Vaccines Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.2 Bharat Serums and Vaccines Antivenom Market Share in Global in 2016
2.10 Serum Biotech
  2.10.1 Business Overview
    2.10.1.1 Serum Biotech Antivenom Description
    2.10.1.2 Serum Biotech Antivenom Headquarter, Main Business and Finance Overview
  2.10.2 Serum Biotech Antivenom Product Introduction
    2.10.2.1 Production Bases, Sales Regions and Major Competitors
    2.10.2.2 Serum Biotech Antivenom Product Introduction
  2.10.3 Serum Biotech Antivenom Sales, Revenue and Market Share
    2.10.3.1 Serum Biotech Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.2 Serum Biotech Antivenom Market Share in Global in 2016

3 GLOBAL ANTIVENOM MARKET COMPETITION, BY MANUFACTURER

3.1 Global Antivenom Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antivenom Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Antivenom Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Antivenom Manufacturer Market Share
  3.4.2 Top 5 Antivenom Manufacturer Market Share
3.5 Market Competition Trend

4 GLOBAL ANTIVENOM MARKET ANALYSIS BY REGIONS

4.1 Global Antivenom Sales, Revenue and Market Share by Regions
  4.1.1 Global Antivenom Sales by Regions (2012-2017)
  4.1.2 Global Antivenom Revenue by Regions (2012-2017)
4.2 North America Antivenom Sales and Growth (2012-2017)
4.3 Europe Antivenom Sales and Growth (2012-2017)
4.4 Asia-Pacific Antivenom Sales and Growth (2012-2017)
4.5 South America Antivenom Sales and Growth (2012-2017)
4.6 Middle East and Africa Antivenom Sales and Growth (2012-2017)

5 NORTH AMERICA ANTIVENOM BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Antivenom Sales, Revenue and Market Share by Countries
  5.1.1 North America Antivenom Sales by Countries (2012-2017)
  5.1.2 North America Antivenom Revenue by Countries (2012-2017)
  5.1.3 USA Antivenom Sales and Growth (2012-2017)
  5.1.4 Canada Antivenom Sales and Growth (2012-2017)
  5.1.5 Mexico Antivenom Sales and Growth (2012-2017)
5.2 North America Antivenom Sales and Revenue (value) by Manufacturers (2016-2017)
  5.2.1 North America Antivenom Sales by Manufacturers (2016-2017)
  5.2.2 North America Antivenom Revenue by Manufacturers (2016-2017)
5.3 North America Antivenom Sales by Type (2012-2017)
5.4 North America Antivenom Sales by Application (2012-2017)

6 EUROPE ANTIVENOM BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Antivenom Sales, Revenue and Market Share by Countries
  6.1.1 Europe Antivenom Sales by Countries (2012-2017)
  6.1.2 Europe Antivenom Revenue by Countries (2012-2017)
  6.1.3 Germany Antivenom Sales and Growth (2012-2017)
  6.1.4 UK Antivenom Sales and Growth (2012-2017)
  6.1.5 France Antivenom Sales and Growth (2012-2017)
  6.1.6 Russia Antivenom Sales and Growth (2012-2017)
  6.1.7 Italy Antivenom Sales and Growth (2012-2017)
6.2 Europe Antivenom Sales and Revenue (value) by Manufacturers (2016-2017)
  6.2.1 Europe Antivenom Sales by Manufacturers (2016-2017)
  6.2.2 Europe Antivenom Revenue by Manufacturers (2016-2017)
6.3 Europe Antivenom Sales by Type (2012-2017)
6.4 Europe Antivenom Sales by Application (2012-2017)

7 ASIA-PACIFIC ANTIVENOM BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Antivenom Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Antivenom Sales by Countries (2012-2017)
  7.1.2 Asia-Pacific Antivenom Revenue by Countries (2012-2017)
  7.1.3 China Antivenom Sales and Growth (2012-2017)
  7.1.4 Japan Antivenom Sales and Growth (2012-2017)
  7.1.5 Korea Antivenom Sales and Growth (2012-2017)
  7.1.6 India Antivenom Sales and Growth (2012-2017)
  7.1.7 Southeast Asia Antivenom Sales and Growth (2012-2017)
7.2 Asia-Pacific Antivenom Sales and Revenue (value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Antivenom Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Antivenom Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Antivenom Sales by Type (2012-2017)
7.4 Asia-Pacific Antivenom Sales by Application (2012-2017)

8 SOUTH AMERICA ANTIVENOM BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Antivenom Sales, Revenue and Market Share by Countries
  8.1.1 South America Antivenom Sales by Countries (2012-2017)
  8.1.2 South America Antivenom Revenue by Countries (2012-2017)
  8.1.3 Brazil Antivenom Sales and Growth (2012-2017)
  8.1.4 Argentina Antivenom Sales and Growth (2012-2017)
  8.1.5 Columbia Antivenom Sales and Growth (2012-2017)
8.2 South America Antivenom Sales and Revenue (value) by Manufacturers (2016-2017)
  8.2.1 South America Antivenom Sales by Manufacturers (2016-2017)
  8.2.2 South America Antivenom Revenue by Manufacturers (2016-2017)
8.3 South America Antivenom Sales by Type (2012-2017)
8.4 South America Antivenom Sales by Application (2012-2017)

9 MIDDLE EAST AND AFRICA ANTIVENOM BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Antivenom Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Antivenom Sales by Countries (2012-2017)
  9.1.2 Middle East and Africa Antivenom Revenue by Countries (2012-2017)
  9.1.3 Saudi Arabia Antivenom Sales and Growth (2012-2017)
  9.1.4 UAE Antivenom Sales and Growth (2012-2017)
  9.1.5 Egypt Antivenom Sales and Growth (2012-2017)
  9.1.6 Nigeria Antivenom Sales and Growth (2012-2017)
  9.1.7 South Africa Antivenom Sales and Growth (2012-2017)
9.2 Middle East and Africa Antivenom Sales and Revenue (value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Antivenom Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Antivenom Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Antivenom Sales by Type (2012-2017)
9.4 Middle East and Africa Antivenom Sales by Application (2012-2017)

10 GLOBAL ANTIVENOM MARKET SEGMENT BY TYPE

10.1 Global Antivenom Sales, Revenue and Market Share by Type (2012-2017)
  10.1.1 Global Antivenom Sales and Market Share by Type (2012-2017)
  10.1.2 Global Antivenom Revenue and Market Share by Type (2012-2017)
10.2 Polyvalent antivenom Sales Growth and Price
  10.2.1 Global Polyvalent antivenom Sales Growth (2012-2017)
  10.2.2 Global Polyvalent antivenom Price (2012-2017)
10.3 Monovalent antivenom Sales Growth and Price
  10.3.1 Global Monovalent antivenom Sales Growth (2012-2017)
  10.3.2 Global Monovalent antivenom Price (2012-2017)

11 GLOBAL ANTIVENOM MARKET SEGMENT BY APPLICATION

11.1 Global Antivenom Sales Market Share by Application (2012-2017)
11.2 Retail Pharmacies Sales Growth (2012-2017)
11.3 Hospitals Sales Growth (2012-2017)
11.4 Others Sales Growth (2012-2017)

12 ANTIVENOM MARKET FORECAST (2017-2022)

12.1 Global Antivenom Sales, Revenue and Growth Rate (2017-2022)
12.2 Antivenom Market Forecast by Regions (2017-2022)
  12.2.1 North America Antivenom Market Forecast (2017-2022)
  12.2.2 Europe Antivenom Market Forecast (2017-2022)
  12.2.3 Asia-Pacific Antivenom Market Forecast (2017-2022)
  12.2.4 South America Antivenom Market Forecast (2017-2022)
  12.2.5 Middle East and Africa Antivenom Market Forecast (2017-2022)
12.3 Antivenom Market Forecast by Type (2017-2022)
12.4 Antivenom Market Forecast by Application (2017-2022)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source


LIST OF TABLES AND FIGURES

Figure Antivenom Picture
Table Product Specifications of Antivenom
Figure Global Sales Market Share of Antivenom by Types in 2016
Table Antivenom Types for Major Manufacturers
Figure Polyvalent antivenom Picture
Figure Monovalent antivenom Picture
Table Antivenom Sales Market Share by Applications in 2016
Figure Retail Pharmacies Picture
Figure Hospitals Picture
Figure Others Picture
Figure USA Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure Canada Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure Mexico Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure Germany Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure France Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure UK Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure China Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure Japan Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure Korea Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure India Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure Southeast Asia Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure Brazil Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Antivenom Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Antivenom Revenue (Value) and Growth Rate (2012-2022)
Table CSL Behring Headquarter, Established, Main Business and Finance Overview (2016)
Table CSL Behring Antivenom Production Bases, Sales Regions and Major Competitors
Table CSL Behring Antivenom Product
Table CSL Behring Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Behring Antivenom Sales Market Share in Global in 2016
Table CSL Behring Antivenom Revenue Market Share in Global in 2016
Table Merck & Co., Inc. Headquarter, Established, Main Business and Finance Overview (2016)
Table Merck & Co., Inc. Antivenom Production Bases, Sales Regions and Major Competitors
Table Merck & Co., Inc. Antivenom Product
Table Merck & Co., Inc. Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co., Inc. Antivenom Sales Market Share in Global in 2016
Table Merck & Co., Inc. Antivenom Revenue Market Share in Global in 2016
Table BTG Plc Headquarter, Established, Main Business and Finance Overview (2016)
Table BTG Plc Antivenom Production Bases, Sales Regions and Major Competitors
Table BTG Plc Antivenom Product
Table BTG Plc Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BTG Plc Antivenom Sales Market Share in Global in 2016
Table BTG Plc Antivenom Revenue Market Share in Global in 2016
Table Pfizer Headquarter, Established, Main Business and Finance Overview (2016)
Table Pfizer Antivenom Production Bases, Sales Regions and Major Competitors
Table Pfizer Antivenom Product
Table Pfizer Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Antivenom Sales Market Share in Global in 2016
Table Pfizer Antivenom Revenue Market Share in Global in 2016
Table Haffkine Bio-Pharmaceutical Corporation Headquarter, Established, Main Business and Finance Overview (2016)
Table Haffkine Bio-Pharmaceutical Corporation Antivenom Production Bases, Sales Regions and Major Competitors
Table Haffkine Bio-Pharmaceutical Corporation Antivenom Product
Table Haffkine Bio-Pharmaceutical Corporation Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Haffkine Bio-Pharmaceutical Corporation Antivenom Sales Market Share in Global in 2016
Table Haffkine Bio-Pharmaceutical Corporation Antivenom Revenue Market Share in Global in 2016
Table Rare Disease Therapeutics Headquarter, Established, Main Business and Finance Overview (2016)
Table Rare Disease Therapeutics Antivenom Production Bases, Sales Regions and Major Competitors
Table Rare Disease Therapeutics Antivenom Product
Table Rare Disease Therapeutics Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Rare Disease Therapeutics Antivenom Sales Market Share in Global in 2016
Table Rare Disease Therapeutics Antivenom Revenue Market Share in Global in 2016
Table Flynn Pharma Headquarter, Established, Main Business and Finance Overview (2016)
Table Flynn Pharma Antivenom Production Bases, Sales Regions and Major Competitors
Table Flynn Pharma Antivenom Product
Table Flynn Pharma Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Flynn Pharma Antivenom Sales Market Share in Global in 2016
Table Flynn Pharma Antivenom Revenue Market Share in Global in 2016
Table Vins Bioproducts Headquarter, Established, Main Business and Finance Overview (2016)
Table Vins Bioproducts Antivenom Production Bases, Sales Regions and Major Competitors
Table Vins Bioproducts Antivenom Product
Table Vins Bioproducts Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Vins Bioproducts Antivenom Sales Market Share in Global in 2016
Table Vins Bioproducts Antivenom Revenue Market Share in Global in 2016
Table Bharat Serums and Vaccines Headquarter, Established, Main Business and Finance Overview (2016)
Table Bharat Serums and Vaccines Antivenom Production Bases, Sales Regions and Major Competitors
Table Bharat Serums and Vaccines Antivenom Product
Table Bharat Serums and Vaccines Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bharat Serums and Vaccines Antivenom Sales Market Share in Global in 2016
Table Bharat Serums and Vaccines Antivenom Revenue Market Share in Global in 2016
Table Serum Biotech Headquarter, Established, Main Business and Finance Overview (2016)
Table Serum Biotech Antivenom Production Bases, Sales Regions and Major Competitors
Table Serum Biotech Antivenom Product
Table Serum Biotech Antivenom Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Serum Biotech Antivenom Sales Market Share in Global in 2016
Table Serum Biotech Antivenom Revenue Market Share in Global in 2016
Table Global Antivenom Sales by Manufacturer (2016-2017)
Figure Global Antivenom Sales Market Share by Manufacturer in 2016
Figure Global Antivenom Sales Market Share by Manufacturer in 2017
Table Global Antivenom Revenue by Manufacturer (2016-2017)
Figure Global Antivenom Revenue Market Share by Manufacturer in 2016
Figure Global Antivenom Revenue Market Share by Manufacturer in 2017
Table Global Antivenom Price by Manufacturer (2016-2017)
Figure Global Antivenom Sales and Growth (2012-2017)
Figure Global Antivenom Revenue and Growth (2012-2017)
Table Global Antivenom Sales by Regions (2012-2017)
Table Global Antivenom Sales Market Share by Regions (2012-2017)
Table Global Antivenom Revenue by Regions (2012-2017)
Figure Global Antivenom Revenue Market Share by Regions in 2012
Figure Global Antivenom Revenue Market Share by Regions in 2016
Figure North America Antivenom Sales and Growth (2012-2017)
Figure Europe Antivenom Sales and Growth (2012-2017)
Figure Asia-Pacific Antivenom Sales and Growth (2012-2017)
Figure South America Antivenom Sales and Growth (2012-2017)
Figure Middle East and Africa Antivenom Sales and Growth (2012-2017)
Figure North America Antivenom Revenue and Growth (2012-2017)
Table North America Antivenom Sales by Countries (2012-2017)
Table North America Antivenom Sales Market Share by Countries (2012-2017)
Figure North America Antivenom Sales Market Share by Countries in 2012
Figure North America Antivenom Sales Market Share by Countries in 2016
Table North America Antivenom Revenue by Countries (2012-2017)
Table North America Antivenom Revenue Market Share by Countries (2012-2017)
Figure North America Antivenom Revenue Market Share by Countries in 2012
Figure North America Antivenom Revenue Market Share by Countries in 2016
Figure USA Antivenom Sales and Growth (2012-2017)
Figure Canada Antivenom Sales and Growth (2012-2017)
Figure Mexico Antivenom Sales and Growth (2012-2017)
Table North America Antivenom Sales by Manufacturer (2016-2017)
Figure North America Antivenom Sales Market Share by Manufacturer in 2016
Figure North America Antivenom Sales Market Share by Manufacturer in 2017
Table North America Antivenom Revenue by Manufacturer (2016-2017)
Figure North America Antivenom Revenue Market Share by Manufacturer in 2016
Figure North America Antivenom Revenue Market Share by Manufacturer in 2017
Table North America Antivenom Sales by Type (2012-2017)
Table North America Antivenom Sales Share by Type (2012-2017)
Table North America Antivenom Sales by Application (2012-2017)
Table North America Antivenom Sales Share by Application (2012-2017)
Figure Europe Antivenom Revenue and Growth (2012-2017)
Table Europe Antivenom Sales by Countries (2012-2017)
Table Europe Antivenom Sales Market Share by Countries (2012-2017)
Table Europe Antivenom Revenue by Countries (2012-2017)
Table Europe Antivenom Revenue Market Share by Countries in 2012
Table Europe Antivenom Revenue Market Share by Countries in 2016
Figure Germany Antivenom Sales and Growth (2012-2017)
Figure UK Antivenom Sales and Growth (2012-2017)
Figure France Antivenom Sales and Growth (2012-2017)
Figure Russia Antivenom Sales and Growth (2012-2017)
Figure Italy Antivenom Sales and Growth (2012-2017)
Table Europe Antivenom Sales by Manufacturer (2016-2017)
Figure Europe Antivenom Sales Market Share by Manufacturer in 2016
Figure Europe Antivenom Sales Market Share by Manufacturer in 2017
Table Europe Antivenom Revenue by Manufacturer (2016-2017)
Figure Europe Antivenom Revenue Market Share by Manufacturer in 2016
Figure Europe Antivenom Revenue Market Share by Manufacturer in 2017
Table Europe Antivenom Sales by Type (2012-2017)
Table Europe Antivenom Sales Share by Type (2012-2017)
Table Europe Antivenom Sales by Application (2012-2017)
Table Europe Antivenom Sales Share by Application (2012-2017)
Figure Asia-Pacific Antivenom Revenue and Growth (2012-2017)
Table Asia-Pacific Antivenom Sales by Countries (2012-2017)
Table Asia-Pacific Antivenom Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Antivenom Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Antivenom Revenue by Countries (2012-2017)
Table Asia-Pacific Antivenom Revenue Market Share by Countries (2012-2017)
Figure China Antivenom Sales and Growth (2012-2017)
Figure Japan Antivenom Sales and Growth (2012-2017)
Figure Korea Antivenom Sales and Growth (2012-2017)
Figure India Antivenom Sales and Growth (2012-2017)
Figure Southeast Asia Antivenom Sales and Growth (2012-2017)
Table Asia-Pacific Antivenom Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Antivenom Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Antivenom Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Antivenom Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Antivenom Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Antivenom Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Antivenom Sales by Type (2012-2017)
Table Asia-Pacific Antivenom Sales Share by Type (2012-2017)
Table Asia-Pacific Antivenom Sales by Application (2012-2017)
Table Asia-Pacific Antivenom Sales Share by Application (2012-2017)
Figure South America Antivenom Revenue and Growth (2012-2017)
Table South America Antivenom Sales by Countries (2012-2017)
Table South America Antivenom Sales Market Share by Countries (2012-2017)
Figure South America Antivenom Sales Market Share by Countries in 2016
Table South America Antivenom Revenue by Countries (2012-2017)
Table South America Antivenom Revenue Market Share by Countries (2012-2017)
Figure South America Antivenom Revenue Market Share by Countries in 2016
Figure South America Antivenom Revenue Market Share by Countries in 2017
Figure Brazil Antivenom Sales and Growth (2012-2017)
Figure Argentina Antivenom Sales and Growth (2012-2017)
Figure Columbia Antivenom Sales and Growth (2012-2017)
Table South America Antivenom Sales by Manufacturer (2016-2017)
Figure South America Antivenom Sales Market Share by Manufacturer in 2016
Figure South America Antivenom Sales Market Share by Manufacturer in 2017
Table South America Antivenom Revenue by Manufacturer (2016-2017)
Figure South America Antivenom Revenue Market Share by Manufacturer in 2016
Figure South America Antivenom Revenue Market Share by Manufacturer in 2017
Table South America Antivenom Sales by Type (2012-2017)
Table South America Antivenom Sales Share by Type (2012-2017)
Table South America Antivenom Sales by Application (2012-2017)
Table South America Antivenom Sales Share by Application (2012-2017)
Figure Middle East and Africa Antivenom Revenue and Growth (2012-2017)
Table Middle East and Africa Antivenom Sales by Countries (2012-2017)
Table Middle East and Africa Antivenom Sales Market Share by Countries (2012-2017)
Figure Middle East and Africa Antivenom Sales Market Share by Countries in 2016
Table Middle East and Africa Antivenom Revenue by Countries (2012-2017)
Table Middle East and Africa Antivenom Revenue Market Share by Countries (2012-2017)
Figure Middle East and Africa Antivenom Revenue Market Share by Countries in 2012
Figure Middle East and Africa Antivenom Revenue Market Share by Countries in 2016
Figure Saudi Arabia Antivenom Sales and Growth (2012-2017)
Figure UAE Antivenom Sales and Growth (2012-2017)
Figure Egypt Antivenom Sales and Growth (2012-2017)
Figure Nigeria Antivenom Sales and Growth (2012-2017)
Figure South Africa Antivenom Sales and Growth (2012-2017)
Table Middle East and Africa Antivenom Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Antivenom Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Antivenom Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Antivenom Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Antivenom Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Antivenom Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Antivenom Sales by Type (2012-2017)
Table Middle East and Africa Antivenom Sales Share by Type (2012-2017)
Table Middle East and Africa Antivenom Sales by Application (2012-2017)
Table Middle East and Africa Antivenom Sales Share by Application (2012-2017)
Table Global Antivenom Sales by Type (2012-2017)
Table Global Antivenom Sales Share by Type (2012-2017)
Table Global Antivenom Revenue by Type (2012-2017)
Table Global Antivenom Revenue Share by Type (2012-2017)
Figure Global Polyvalent antivenom Sales Growth (2012-2017)
Figure Global Polyvalent antivenom Price (2012-2017)
Figure Global Monovalent antivenom Sales Growth (2012-2017)
Figure Global Monovalent antivenom Price (2012-2017)
Table Global Antivenom Sales by Application (2012-2017)
Table Global Antivenom Sales Share by Application (2012-2017)
Figure Global Retail Pharmacies Sales Growth (2012-2017)
Figure Global Hospitals Sales Growth (2012-2017)
Figure Global Others Sales Growth (2012-2017)
Figure Global Antivenom Sales, Revenue and Growth Rate (2017 -2022)
Table Global Antivenom Sales Forecast by Regions (2017-2022)
Table Global Antivenom Market Share Forecast by Regions (2017-2022)
Figure North America Sales Antivenom Market Forecast (2017-2022)
Figure Europe Sales Antivenom Market Forecast (2017-2022)
Figure Asia-Pacific Sales Antivenom Market Forecast (2017-2022)
Figure South America Sales Antivenom Market Forecast (2017-2022)
Figure Middle East and Africa Sales Antivenom Market Forecast (2017-2022)
Table Global Antivenom Sales Forecast by Type (2017-2022)
Table Global Antivenom Market Share Forecast by Type (2017-2022)
Table Global Antivenom Sales Forecast by Application (2017-2022)
Table Global Antivenom Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List


More Publications